REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Eversana Poland Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Eversana Poland Sp. z o.o. Profile Updated: May 19, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Eversana Poland Sp. z o.o. is based in Poland. The head office is in Warsaw. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. It was incorporated on September 25, 2019. From the latest financial highlights, Eversana Poland Sp. z o.o. reported a net sales revenue increase of 139.34% in 2023. Its’ total assets recorded a growth of 83.48%. In, 2023, the company’s net profit margin decreased by 15.72%.

Headquarters
Ul. Towarowa 28
Warsaw; Mazowieckie; Postal Code: 00-839

Contact Details: Purchase the Eversana Poland Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Eversana Poland Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Eversana Poland Sp. z o.o. report to view the information.
Incorporation Date:
September 25, 2019
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Eversana Poland Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
139.34%▲
Total operating revenue
104.84%▲
Operating profit (EBIT)
-14.64%▼
Net Profit (Loss) for the Period
-21.4%▼
Total assets
83.48%▲
Total equity
78.42%▲
Operating Profit Margin (ROS)
-16.67%▼
Net Profit Margin
-15.72%▼
Return on Equity (ROE)
-55.82%▼
Quick Ratio
-0.07%▼
Cash Ratio
-0.69%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo